SEC Form 4/A · accession 0001358403-15-000033
BELLICUM PHARMACEUTICALS, INC · BLCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David M. Spencer
Officer — Chief Scientific Officer
Period of report
Jun 16, 2015
Accepted (ET)
Jun 19, 2015 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358403
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jun 16, 2015 | S | 17,200 | $22.8227 | D | 166,400 | D | |
| Common StockF4,F3 | Jun 16, 2015 | S | 2,800 | $23.7939 | D | 163,600 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 23, 2015.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.52 to $23.51. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3Includes 846 shares acquired under the Issuer's Employee Stock Purchase Plan on June 10, 2015. These shares were inadvertently omitted from the Reporting Person's original Form 4 filed with the SEC on June 18, 2015
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.52 to $24.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.